[1]
Ahmad, B., Ahmad, S., Inayat, K., Bilal, S.S., Arbab, A. and Khan, U.A. 2023. Tolerance of sorafenib in patients with residual HCC post TACE. International journal of health sciences. 6, S10 (Mar. 2023), 1427–1434. DOI:https://doi.org/10.53730/ijhs.v6nS10.14038.